Muscle Strength, Metabolism, and Recovery

Evidence Review

Key Human Trial: Isenmann et al. (2019)

The pivotal human trial was conducted at Freie Universität Berlin and published in Archives of Toxicology (PMID 31123801). Forty-six male recreational athletes participated in a 10-week randomized, double-blind, placebo-controlled study. Participants were divided into three groups — placebo, low-dose ecdysterone (200 mg/day), and high-dose ecdysterone (800 mg/day) — all engaged in standardized resistance training.

The high-dose group showed statistically significant increases in lean muscle mass compared to placebo (p < 0.05) and greater bench-press one-repetition maximum strength gains. Body weight in the high-dose group increased by approximately 3 kg over ten weeks, with the ecdysterone arm attributing more of this to lean mass than the placebo arm, which lost a mean 0.35 kg of lean mass. Blood and urine tests showed no signs of hepatic toxicity, renal toxicity, or hormonal disruption — testosterone, LH, FSH, and estradiol levels were unchanged from baseline across all groups.

The investigators formally recommended to the German Olympic Sports Confederation and WADA that ecdysterone be added to the monitoring list, citing effect sizes they described as exceeding some banned anabolic agents in parallel animal studies. Limitations include the 10-week duration, all-male cohort, and the fact that dose-response at levels below 200 mg was not tested.

Spinach Extract in Older Adults: Pérez-Piñero et al. (2021)

A 12-week double-blind RCT (PMID 34959924) enrolled 50 adults over 50 years old and randomized them to spinach extract (2 g/day) or placebo, combined with a moderate-intensity training program of 3 sessions per week. The spinach extract group showed significantly greater improvements in handgrip strength, appendicular muscle mass index, and functional performance measures (sit-to-stand test, walking speed) compared to placebo.

This study is particularly important because it extends ecdysterone research beyond young male athletes to an older population where muscle preservation is a major health concern. Sarcopenia — the progressive loss of muscle mass with aging — is a major driver of falls, frailty, and loss of independence. A safe, plant-derived compound that supports muscle mass during exercise training in this population would be a meaningful clinical tool. The study used spinach extract rather than purified ecdysterone, which reflects more naturalistic supplementation but makes it harder to isolate the effect of ecdysterone alone.

Mechanism: ERβ and Hypertrophy Pathway

Parr et al. (PMID 24974955) established the molecular mechanism in vitro and in vivo. They demonstrated that ecdysterone binds estrogen receptor beta with high affinity (ED₅₀ = 13 nM in reporter assays), activates the PI3K/Akt/mTOR protein synthesis cascade, and that blocking ERβ with a selective antagonist completely abolished ecdysterone-induced hypertrophy in C2C12 myocytes. They also compared ecdysterone head-to-head with metandienone (Dianabol), estradienedione (Trenbolox), and SARM S1 in a rat soleus muscle model — all at the same dose — and ecdysterone produced the largest increase in muscle fiber cross-sectional area. The selectivity for ERβ over ERα likely explains the absence of feminizing effects, as ERα drives reproductive tissue responses while ERβ in skeletal muscle drives anabolic signaling.

Negative Study: Wilborn et al. (2006)

An earlier study (PMID 18500969) found no significant effects of ecdysterone (200 mg/day for 8 weeks) in 45 resistance-trained males on body composition, strength, or hormone levels, using commercially available supplements. This apparent contradiction with the Isenmann study likely reflects product quality: commercial ecdysterone supplements in 2006 were poorly standardized, and actual ecdysterone content in commercial products has since been shown to frequently deviate significantly from label claims. The Isenmann protocol used pharmaceutical-grade research-grade ecdysterone, whereas the Wilborn study used off-the-shelf products. This highlights an important practical caveat: for consumers, supplement quality and verified ecdysterone content matter far more than the dose stated on the label.

Broader Therapeutic Potential: Dinan et al. (2021)

The comprehensive review by Dinan et al. (PMID 33947076) examined the full therapeutic landscape for 20-hydroxyecdysone across neuromuscular, metabolic, and cardiovascular applications. Key findings from pre-clinical models include: improved insulin sensitivity and reduced fasting blood glucose comparable to metformin in some models; reduced total cholesterol and triglycerides; anti-fibrotic effects in liver and lung tissue; and preservation of muscle mass in atrophy models. The MAS1 receptor appears to be a central target, linking ecdysterone's effects to the protective arm of the renin-angiotensin system. Most importantly, this review notes that 20-hydroxyecdysone entered Phase 2/3 clinical trials (as BIO101, developed by Biophytis) for age-related sarcopenia and for severe COVID-19 respiratory failure — the most rigorous human evidence context for any ecdysteroid compound, providing strong validation of both safety and potential efficacy.

Evidence Strength Assessment

The evidence for ecdysterone on muscle hypertrophy and strength in people who exercise is moderate-positive: one well-designed RCT in young male athletes showed meaningful gains at 800 mg/day of purified ecdysterone; a second RCT in adults over 50 showed functional improvements with spinach extract. A third earlier study showed null results, most likely due to product quality. Mechanistic evidence at the molecular level is solid. Longer trials (16–24 weeks), female cohorts, and diverse populations are needed to fully establish the evidence base. The safety profile to date is favorable across all human studies, with no hormonal disruption or toxicity signals. For people engaged in consistent resistance training and seeking well-sourced, research-grade supplementation, ecdysterone represents one of the more scientifically interesting plant-derived compounds of the past decade.